Molemax

MoleMax™ was the first digital epiluminescence microscopy (dermatoscopy) system developed in cooperation with medical faculty Department of Dermatology of the Medical University of Vienna. It is currently owned and distributed by DermaMedicalSystems.

History

In 1997 MoleMax™ was presented to international experts at the Melanoma World Congress and the following Dermatology World Congress in Sydney and generated great public interest. Since then over 2000 MoleMax systems are in use in over 50 countries. Today MoleMax is worldwide accepted clinical standard in digital epiluminescence microscopy.

Methodology

Thanks to the worldwide patented light polarisation technique for cameras with skin contact, these camera systems do not require any immersion fluid for the epiluminescence microscopic analysis.

Scientific use

The MoleMax™ system was part of multiple scientific works such as measurements of the growth rate of pigmented skin lesions [1] ,[2] and verification of follow-up imaging [3] . Images made by this system also ended up in large public image databases such as HAM10000 .[4]

gollark: There's a game on my website where you just click a button to increment and decrement a number.
gollark: I have a complex Node.js application up *purely* for "remote debugging" of an "OS" for a computer mod for Minecraft.
gollark: I actually run about 1/3 of an IRC network.
gollark: I mean, I use that for personal-use services like an online RSS reader too, but the great majority of the configuration (and hassle with it) is for my many stupid things.
gollark: I just spent several hours today (well, probably about 2) reconfiguring some DNS/HTTPS certificate stuff just so I can have a mildly technically better way to share my random internet junk™ with the world.

References
  1. Beer, J; Xu, L; Tschandl, P; Kittler, H (2011). "Growth rate of melanoma in vivo and correlation with dermatoscopic and dermatopathologic findings". Dermatology Practical & Conceptual. 1 (1): 59–67. doi:10.5826/dpc.dp0101a13 (inactive 2020-05-08). PMC 3881085. PMID 24396722.
  2. Tschandl, P; Berghoff, AS; Preusser, M; Pammer, J; Pehamberger, H; Kittler, H (February 2016). "Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo". The British Journal of Dermatology. 174 (2): 364–70. doi:10.1111/bjd.14323. PMID 26613644.
  3. Salerni, G; Terán, T; Puig, S; Malvehy, J; Zalaudek, I; Argenziano, G; Kittler, H (July 2013). "Meta-analysis of digital dermoscopy follow-up of melanocytic skin lesions: a study on behalf of the International Dermoscopy Society". Journal of the European Academy of Dermatology and Venereology : JEADV. 27 (7): 805–14. doi:10.1111/jdv.12032. PMID 23181611.
  4. Tschandl, P; Rosendahl, C; Kittler, H (14 August 2018). "The HAM10000 dataset, a large collection of multi-source dermatoscopic images of common pigmented skin lesions". Scientific Data. 5: 180161. arXiv:1803.10417. Bibcode:2018NatSD...580161T. doi:10.1038/sdata.2018.161. PMC 6091241. PMID 30106392.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.